Oxford Glycosciences' IPO

Oxford Glycosciences raised a round of funding on April 08, 1998. Investors include Public.

was a technology developer in the fields of glycobiology and proteomics. Utilizing its technology, the company developed a lead pharmaceutical product Zavesca, that was approved by the European Commis…

Articles about Oxford Glycosciences' IPO: